Exploring NASDAQ:CPRX's high growth characteristics.

CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) has been identified as a Technical Breakout Setup Pattern by our stock screener. This pattern typically occurs when a stock takes a pause after a significant rise, indicating the possibility of a continuation in the trend. While it's impossible to predict with certainty, it might be beneficial to monitor NASDAQ:CPRX.

Insights from Technical Analysis

ChartMill assigns a Technical Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple technical indicators and properties.

Taking everything into account, CPRX scores 10 out of 10 in our technical rating. This is due to a consistent performance in both the short and longer term time frames. Also compared to the overall market, CPRX is showing a nice and steady performance.

• The long and short term trends are both positive. This is looking good!
• Looking at the yearly performance, CPRX did better than 89% of all other stocks. We also observe that the gains produced by CPRX over the past year are nicely spread over this period.
• CPRX is one of the better performing stocks in the Biotechnology industry, it outperforms 87% of 572 stocks in the same industry.
• CPRX is currently trading in the upper part of its 52 week range. The S&P500 Index however is currently trading near a new high, so CPRX is lagging the market slightly.
• CPRX is currently showing a bull flag pattern! A bull flag pattern occurs when prices pull back slightly after a strong rise up. This may be a nice opportunity for an entry.

Our latest full technical report of CPRX contains the most current technical analsysis.

How do we evaluate the setup for NASDAQ:CPRX?

Alongside the Technical Rating, ChartMill assigns a Setup Rating to evaluate the consolidation level of a stock. This rating, ranging from 0 to 10, is updated daily and considers various short-term technical indicators. The current setup rating for NASDAQ:CPRX is 8:

Besides having an excellent technical rating, CPRX also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is a resistance zone just above the current price starting at 23.93. Right above this resistance zone may be a good entry point. Very recently a Pocket Pivot signal was observed. This is another positive sign.

Looking into the high growth metrics of CATALYST PHARMACEUTICALS INC

• With a favorable trend in its quarter-to-quarter (Q2Q) earnings per share (EPS), CATALYST PHARMACEUTICALS INC highlights its ability to generate increasing profitability, showcasing a 221.0% growth.
• The recent q2q revenue growth of 25.33% of CATALYST PHARMACEUTICALS INC showcases the company's ability to generate increasing revenue in a short period, reflecting its positive growth trajectory.
• The 3-year EPS growth of CATALYST PHARMACEUTICALS INC (25.48%) highlights the company's ability to consistently improve its earnings performance and suggests a positive outlook for future profitability.
• CATALYST PHARMACEUTICALS INC has achieved significant 1-year revenue growth of 32.13%, signaling its ability to capture market opportunities and drive top-line expansion. This growth indicates the company's effective execution and its potential for continued success.
• The average next Quarter EPS Estimate for CATALYST PHARMACEUTICALS INC has experienced a 29.23% change in the last 3 months, reflecting evolving expectations by analysts regarding the company's EPS performance.
• The quarterly earnings of CATALYST PHARMACEUTICALS INC have shown a 221.0% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
• accelerating EPS growth for CATALYST PHARMACEUTICALS INC: the current Q2Q growth of 221.0% exceeds the previous year Q2Q growth of -245.0%.
• The operating margin of CATALYST PHARMACEUTICALS INC has seen steady growth over the past year, signaling improved profitability. This trend indicates the company's effective cost management and its ability to generate higher returns.
• CATALYST PHARMACEUTICALS INC has shown positive growth in its free cash flow (FCF) over the past year, indicating improved cash generation and financial strength. This growth highlights the company's ability to effectively manage its cash flows and generate surplus funds.
• The Return on Equity (ROE) of CATALYST PHARMACEUTICALS INC stands at 21.61%, reflecting the company's strong profitability and effective utilization of shareholder equity. This metric signifies the company's ability to generate returns for its investors.
• With a Debt-to-Equity ratio at 0.0, CATALYST PHARMACEUTICALS INC showcases its prudent financial management. The company's balanced approach between debt and equity reflects its commitment to maintaining a stable capital structure.
• CATALYST PHARMACEUTICALS INC demonstrates a balanced ownership structure, with institutional shareholders at 83.84%. This indicates a diverse investor base, which can contribute to price stability and potential future growth.
• With a track record of beating EPS estimates in the last 4 quarters, CATALYST PHARMACEUTICALS INC showcases its consistent ability to deliver earnings surprises. This reflects the company's strong execution and its competitive position in the market.
• The Relative Strength (RS) of CATALYST PHARMACEUTICALS INC has consistently been strong, with a current 89.04 rating. This indicates the stock's ability to exhibit relative price outperformance and reflects its competitive strength. CATALYST PHARMACEUTICALS INC demonstrates promising potential for sustained price momentum.

More ideas for high growth momentum breakouts can be found on ChartMill in our High Growth Momentum Breakout screen.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.